All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0087 | Anti-DYNC1I2 (CBYCJ-014) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-014 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0088 | Anti-DYNC1I2 (74.1) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Bovine | 74.1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0089 | Anti-DYNC1I2 (CBYCJ-015) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-015 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0710 | Anti-DYNC1I2 (CBYCD-459) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-459 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0987 | Anti-DYNC1I2 (CBYCJ-014) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-014 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0988 | Anti-DYNC1I2 (74.1) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Bovine | 74.1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0989 | Anti-DYNC1I2 (CBYCJ-015) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-015 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1610 | Anti-DYNC1I2 (CBYCD-459) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-459 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION